Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), bought 930 shares at $10.75 ($10K) on 2012-02-21, disclosed to the SEC on 2012-02-23.
Open-market purchase of $10k ALNY by SVP, Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |